Rules 4.7.3 and 4.10.3
Appendix 4G
Key to Disclosures
Corporate Governance Council Principles and Recommendations
Name of entity
Telix Pharmaceuticals Limited
ABN/ARBN |
Financial year ended: |
|
85 616 620 369 |
31 December 2021 |
|
Our corporate governance statement1 for the period above can be found at:2
- These pages of our annual report:
The Corporate Governance Statement is accurate and up to date as at 28 February 2022 and has been approved by the Board.
The annexure includes a key to where our corporate governance disclosures can be located.3 Date: 28 February 2022
Name of authorised officer authorising lodgement: Melanie Farris, Group Company Secretary
- “Corporate governance statement” is defined in Listing Rule 19.12 to mean the statement referred to in Listing Rule 4.10.3 which discloses the extent to which an entity has followed the recommendations set by the ASX Corporate Governance Council during a particular reporting period.
Listing Rule 4.10.3 requires an entity that is included in the official list as an ASX Listing to include in its annual report either a corporate governance statement that meets the requirements of that rule or the URL of the page on its website where such a statement is located. The corporate governance statement must disclose the extent to which the entity has followed the recommendations set by the ASX Corporate Governance Council during the reporting period. If the entity has not followed a recommendation for any part of the reporting period, its corporate governance statement must separately identify that recommendation and the period during which it was not followed and state its reasons for not following the recommendation and what (if any) alternative governance practices it adopted in lieu of the recommendation during that period.
Under Listing Rule 4.7.4, if an entity chooses to include its corporate governance statement on its website rather than in its annual report, it must lodge a copy of the corporate governance statement with ASX at the same time as it lodges its annual report with ASX. The corporate governance statement must be current as at the effective date specified in that statement for the purposes of Listing Rule 4.10.3.
Under Listing Rule 4.7.3, an entity must also lodge with ASX a completed Appendix 4G at the same time as it lodges its annual report with ASX. The Appendix 4G serves a dual purpose. It acts as a key designed to assist readers to locate the governance disclosures made by a listed entity under Listing Rule 4.10.3 and under the ASX Corporate Governance Council’s recommendations. It also acts as a verification tool for listed entities to confirm that they have met the disclosure requirements of Listing Rule 4.10.3.
The Appendix 4G is not a substitute for, and is not to be confused with, the entity’s corporate governance statement. They serve different purposes and an entity must produce each of them separately.
- Tick whichever option is correct and then complete the page number(s) of the annual report, or the URL of the web page, where your corporate governance statement can be found. You can, if you wish, delete the option which is not applicable.
- Throughout this form, where you are given two or more options to select, you can, if you wish, delete any option which is not applicable and just retain the option that is applicable. If you select an option that includes “OR” at the end of the selection and you delete the other options, you can also, if you wish, delete the “OR” at the end of the selection.
See notes 4 and 5 below for further instructions on how to complete this form.
ASX Listing Rules Appendix 4G (current at 17/7/2020) |
Page 1 |
Appendix 4G
Key to Disclosures Corporate Governance Council Principles and Recommendations
ANNEXURE – KEY TO CORPORATE GOVERNANCE DISCLOSURES
Corporate Governance Council recommendation |
Where a box below is ticked,4 we have followed the |
Where a box below is ticked, we have NOT followed the |
|
recommendation in fullfor the wholeof the period above. We |
recommendation in full for the whole of the period above. Our |
||
have disclosed this in our Corporate Governance Statement: |
reasons for not doing so are:5 |
||
PRINCIPLE 1 – LAY SOLID FOUNDATIONS FOR MANAGEMENT AND OVERSIGHT |
|||
1.1 |
A listed entity should have and disclose a board charter setting |
☒ |
☐ set out in our Corporate Governance Statement OR |
out: |
and we have disclosed a copy of our board charter at: |
☐ we are an externally managed entity and this recommendation |
|
(a) the respective roles and responsibilities of its board and |
|||
The “Investors” section of the Telix website at: |
is therefore not applicable |
||
management; and |
|||
(b) those matters expressly reserved to the board and those |
|||
governance/ |
|||
delegated to management. |
|||
1.2 |
A listed entity should: |
☒ |
☐ set out in our Corporate Governance Statement OR |
(a) undertake appropriate checks before appointing a director or |
☐ we are an externally managed entity and this recommendation |
||
senior executive or putting someone forward for election as |
is therefore not applicable |
||
a director; and |
|||
(b) provide security holders with all material information in its |
|||
possession relevant to a decision on whether or not to elect |
|||
or re-elect a director. |
|||
1.3 |
A listed entity should have a written agreement with each director |
☒ |
☐ set out in our Corporate Governance Statement OR |
and senior executive setting out the terms of their appointment. |
☐ we are an externally managed entity and this recommendation |
||
is therefore not applicable |
|||
1.4 |
The company secretary of a listed entity should be accountable |
☒ |
☐ set out in our Corporate Governance Statement OR |
directly to the board, through the chair, on all matters to do with |
☐ we are an externally managed entity and this recommendation |
||
the proper functioning of the board. |
|||
is therefore not applicable |
|||
- Tick the box in this column only if you have followed the relevant recommendation in fullfor the wholeof the period above. Where the recommendation has a disclosure obligation attached, you must insert the location where that disclosure has been made, where indicated by the line with “insert location” underneath. If the disclosure in question has been made in your corporate governance statement, you need only insert “our corporate governance statement”. If the disclosure has been made in your annual report, you should insert the page number(s) of your annual report (eg “pages 10-12 of our annual report”). If the disclosure has been made on your website, you should insert the URL of the web page where the disclosure has been made or can be accessed (eg “www.entityname.com.au/corporate governance/charters/”).
- If you have followed all of the Council’s recommendations in fullfor the wholeof the period above, you can, if you wish, delete this column from the form and re-format it.
ASX Listing Rules Appendix 4G (current at 17/7/2020) |
Page 2 |
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations
Corporate Governance Council recommendation |
Where a box below is ticked,4 we have followed the |
Where a box below is ticked, we have NOT followed the |
|
recommendation in fullfor the wholeof the period above. We |
recommendation in full for the whole of the period above. Our |
||
have disclosed this in our Corporate Governance Statement: |
reasons for not doing so are:5 |
||
1.5 |
A listed entity should: |
☒ |
☐ set out in our Corporate Governance Statement OR |
(a) have and disclose a diversity policy; |
and we have disclosed a copy of our diversity policy at: |
☐ we are an externally managed entity and this recommendation |
|
(b) through its board or a committee of the board set |
The “Investors” section of the Telix website at: |
is therefore not applicable |
|
measurable objectives for achieving gender diversity in the |
|||
composition of its board, senior executives and workforce |
|||
generally; and |
governance/ |
||
(c) disclose in relation to each reporting period: |
and we have disclosed the information referred to in paragraph (c) at |
||
(1) the measurable objectives set for that period to |
page 2 of the Corporate Governance Statement |
||
achieve gender diversity; |
and if we were included in the S&P / ASX 300 Index at the |
||
(2) the entity’s progress towards achieving those |
|||
objectives; and |
commencement of the reporting period our measurable objective for |
||
(3) either: |
achieving gender diversity in the composition of its board of not less |
||
than 30% of its directors of each gender within a specified period |
|||
(A) the respective proportions of men and women |
|||
is recorded at page 2 of the Corporate Governance Statement |
|||
on the board, in senior executive positions and |
|||
across the whole workforce (including how the |
|||
entity has defined “senior executive” for these |
|||
purposes); or |
|||
(B) if the entity is a “relevant employer” under the |
|||
Workplace Gender Equality Act, the entity’s |
|||
most recent “Gender Equality Indicators”, as |
|||
defined in and published under that Act. |
|||
If the entity was in the S&P / ASX 300 Index at the |
|||
commencement of the reporting period, the measurable objective |
|||
for achieving gender diversity in the composition of its board |
|||
should be to have not less than 30% of its directors of each |
|||
gender within a specified period. |
|||
1.6 |
A listed entity should: |
☒ |
☐ set out in our Corporate Governance Statement OR |
(a) have and disclose a process for periodically evaluating the |
and we have disclosed the evaluation process referred to in |
☐ we are an externally managed entity and this recommendation |
|
performance of the board, its committees and individual |
paragraph (a) at: |
is therefore not applicable |
|
directors; and |
Section 1.6 of the Corporate Governance Statement |
||
(b) disclose for each reporting period whether a performance |
|||
and whether a performance evaluation was undertaken for the |
|||
evaluation has been undertaken in accordance with that |
|||
reporting period in accordance with that process at: |
|||
process during or in respect of that period. |
|||
Section 1.6 of the Corporate Governance Statement |
|||
ASX Listing Rules Appendix 4G (current at 17/7/2020) |
Page 3 |
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations
Corporate Governance Council recommendation |
Where a box below is ticked,4 we have followed the |
Where a box below is ticked, we have NOT followed the |
|
recommendation in fullfor the wholeof the period above. We |
recommendation in full for the whole of the period above. Our |
||
have disclosed this in our Corporate Governance Statement: |
reasons for not doing so are:5 |
||
1.7 |
A listed entity should: |
☒ |
☐ set out in our Corporate Governance Statement OR |
(a) have and disclose a process for evaluating the performance |
and we have disclosed the evaluation process referred to in |
☐ we are an externally managed entity and this recommendation |
|
of its senior executives at least once every reporting period; |
paragraph (a) at: |
is therefore not applicable |
|
and |
Section 1.7 of the Corporate Governance Statement and in the |
||
(b) disclose for each reporting period whether a performance |
|||
Remuneration Report available from page 44 in the FY21 |
|||
evaluation has been undertaken in accordance with that |
|||
Annual Report |
|||
process during or in respect of that period. |
|||
and whether a performance evaluation was undertaken for the |
|||
reporting period in accordance with that process at: |
|||
Section 1.7 of the Corporate Governance Statement and in the |
|||
Remuneration Report available from page 44 in the FY21 |
|||
Annual Report |
|||
ASX Listing Rules Appendix 4G (current at 17/7/2020) |
Page 4 |
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations
Corporate Governance Council recommendation |
Where a box below is ticked,4 we have followed the |
Where a box below is ticked, we have NOT followed the |
|
recommendation in fullfor the wholeof the period above. We |
recommendation in full for the whole of the period above. Our |
||
have disclosed this in our Corporate Governance Statement: |
reasons for not doing so are:5 |
||
PRINCIPLE 2 – STRUCTURE THE BOARD TO BE EFFECTIVE AND ADD VALUE |
|||
2.1 |
The board of a listed entity should: |
☒ |
☐ set out in our Corporate Governance Statement OR |
(a) have a nomination committee which: |
[If the entity complies with paragraph (a):] |
☐ we are an externally managed entity and this recommendation |
|
(1) has at least three members, a majority of whom are |
and we have disclosed a copy of the charter of the committee at: |
is therefore not applicable |
|
independent directors; and |
|||
The “Investors” section of the Telix website at: |
|||
(2) is chaired by an independent director, |
|||
and disclose: |
|||
governance/ |
|||
(3) the charter of the committee; |
|||
and the information referred to in paragraphs (4) and (5) at: |
|||
(4) the members of the committee; and |
|||
Section 2.1 of the Corporate Governance Statement and in the |
|||
(5) as at the end of each reporting period, the number |
|||
Directors’ Report from page 35 in the FY21 Annual Report |
|||
of times the committee met throughout the period |
|||
and the individual attendances of the members at |
[If the entity complies with paragraph (b):] |
||
those meetings; or |
|||
(b) if it does not have a nomination committee, disclose that |
and we have disclosed the fact that we do not have a nomination |
||
fact and the processes it employs to address board |
committee and the processes we employ to address board |
||
succession issues and to ensure that the board has the |
succession issues and to ensure that the board has the appropriate |
||
appropriate balance of skills, knowledge, experience, |
balance of skills, knowledge, experience, independence and |
||
independence and diversity to enable it to discharge its |
diversity to enable it to discharge its duties and responsibilities |
||
duties and responsibilities effectively. |
effectively at: |
||
…………………………………………………………………………….. |
|||
[insert location] |
|||
2.2 |
A listed entity should have and disclose a board skills matrix |
☒ |
☐ set out in our Corporate Governance Statement OR |
setting out the mix of skills that the board currently has or is |
and we have disclosed our board skills matrix at: |
☐ we are an externally managed entity and this recommendation |
|
looking to achieve in its membership. |
|||
Section 2.2 of the Corporate Governance Statement |
is therefore not applicable |
||
ASX Listing Rules Appendix 4G (current at 17/7/2020) |
Page 5 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Disclaimer
Telix Pharmaceuticals Ltd. published this content on 28 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 February 2022 01:21:00 UTC.
Publicnow 2022
|
|
|
|
|
||||
|
||||
Technical analysis trends TELIX PHARMACEUTICALS LIMITED
Short Term | Mid-Term | Long Term | |
Trends | Bearish | Bearish | Neutral |
Income Statement Evolution
Sell ![]() Buy |
|
Mean consensus | BUY |
Number of Analysts | 5 |
Last Close Price | 5,19 AUD |
Average target price | 8,23 AUD |
Spread / Average Target | 58,6% |